Non-Sedating Medications for Anxiety, Restlessness, and Agitation
Given your exclusion of opioids and psychiatric medications, the most practical non-sedating option is caffeine or psychostimulants like methylphenidate or modafinil, though these are paradoxically used more for sedation reversal than primary anxiety treatment. However, this creates a clinical dilemma because the most effective evidence-based treatments for anxiety, restlessness, and agitation are psychiatric medications, which you've excluded.
The Core Problem
Your question essentially asks for anxiety treatment while excluding the medications designed to treat anxiety. The evidence base overwhelmingly supports psychiatric medications (SSRIs, SNRIs, antipsychotics, benzodiazepines) as first-line treatments 1, 2, 3, 4. When you exclude these, you're left with limited options that have minimal evidence for treating anxiety as a primary indication.
Available Non-Psychiatric Options
Beta-Blockers (Propranolol, Betaxolol)
- These are your most viable option for situational anxiety, particularly when physical symptoms (tremor, tachycardia, sweating) predominate 5, 6
- Work by blocking peripheral adrenergic symptoms rather than central anxiety mechanisms
- Propranolol and betaxolol concentrate well in the brain when taken orally 5
- Not sedating and can be used for performance anxiety or acute situational stress
- Caveat: Contraindicated in asthma, bradycardia, heart block, and hypotension
Antihistamines (Hydroxyzine)
- FDA-approved for anxiety 3
- Major limitation: Despite being classified as "non-psychiatric," hydroxyzine is inherently sedating, which contradicts your non-sedating requirement
- This option fails your criteria
Buspirone
- Acts on 5-HT mechanisms 6
- Technically a psychiatric medication (anxiolytic), so excluded by your criteria
- Non-sedating profile but takes 2-4 weeks for effect
The Clinical Reality
The evidence shows that effective non-sedating anxiety treatment without psychiatric medications essentially doesn't exist 2, 3, 6. Here's why:
- Anxiety disorders require modulation of neurotransmitter systems (serotonin, GABA, norepinephrine)
- Medications that affect these systems are classified as psychiatric medications
- Non-psychiatric medications that reduce anxiety (like beta-blockers) only address peripheral symptoms, not core anxiety
For Agitation Specifically
If the agitation is related to delirium or medical illness, the guideline approach emphasizes 1:
- Identify and treat reversible causes first (hypoxia, infection, metabolic derangements, medication toxicity)
- Maximize non-pharmacologic interventions (reorientation, cognitive stimulation, sleep hygiene, person-centered care)
- Eliminate delirium-inducing medications (steroids, anticholinergics)
- Reduce or eliminate benzodiazepines if already prescribed
Without psychiatric medications, you're limited to treating underlying medical causes rather than the agitation itself 1.
Practical Algorithm
For anxiety with predominantly physical symptoms:
- Start propranolol 10-40 mg as needed, 30-60 minutes before anxiety-provoking situations
- Monitor blood pressure and heart rate
- Avoid in patients with asthma, COPD, or cardiac conduction disease
For restlessness/agitation in medical illness:
- Identify reversible causes (pain, urinary retention, constipation, hypoxia, infection)
- Optimize environmental factors (lighting, noise reduction, familiar objects)
- Consider if stimulant medications (caffeine, methylphenidate) might help if the issue is actually sedation-related restlessness 1
Critical Caveat
Your exclusion criteria eliminate the evidence-based treatments for these conditions. The medical literature does not support effective non-sedating anxiety management without psychiatric medications 2, 3, 6. If you're avoiding psychiatric medications due to concerns about sedation, note that SSRIs/SNRIs are generally non-sedating and represent first-line treatment 2, 3. If you're avoiding them for other reasons (stigma, formulary restrictions, scope of practice), this represents a significant treatment limitation that should be reconsidered or prompt referral to appropriate specialists.